Comparison

Propofol-d18 European Partner

Item no. HY-B0649S1-1ea
Manufacturer MedChem Express
CASRN 1189467-93-3
Amount 1ea
Category
Type Molecules
Specific against other
Purity 96.98
Citations [1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216. <br>[2]R Nadeson, et al. Antinociceptive Properties of Propofol: Involvement of Spinal Cord Gamma-Aminobutyric acid(A) Receptors. J Pharmacol Exp Ther . 1997 Sep;282(3):1181-6.
Smiles [2H]C([2H])([2H])C(C1=C(C(C(C([2H])([2H])[2H])([2H])C([2H])([2H])[2H])=C([2H])C([2H])=C1[2H])O[2H])([2H])C([2H])([2H])[2H]
ECLASS 10.1 32169090
ECLASS 11.0 32169090
UNSPSC 12000000
Available
Product Description
Propofol-d18 is the deuterium labeled Propofol. Propofol potently and directly activates GABAA receptor and inhibits glutamate receptor mediated excitatory synaptic transmission[1].
StorageTemperature
-20°C, 3 years; 4°C, 2 years (Powder)
Shipping
Room Temperature
MolecularWeight
196.38
Clinical_Information
No Development Reported
Manufacturers Research_Area
Neurological Disease
Solubility
DMSO : 50 mg/mL (ultrasonic)
Manufacturers Target
Endogenous Metabolite; GABA Receptor
Pathway
Membrane Transporter/Ion Channel; Metabolic Enzyme/Protease; Neuronal Signaling
Manufacturers Product type
Isotope-Labeled Compounds

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 1ea
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close